Emflaza

Gyártó: Lupin

Betegségek: Duchenne Muscular Dystrophy / DMD

Az Emflaza egy kortikoszteroid a Duchenne-izomdisztrófia (DMD) kezelésére, 5 éves és idősebb betegek számára.

6mg

Csomagolás	Megtakarítás	Per tabletta	Ár
180 tablettát	Ft 82517.54	Ft 259.30	Ft 46673.14

120 tablettát	Ft 50228.85	Ft 299.15	Ft 35898.27

90 tablettát	Ft 32288.69	Ft 358.96	Ft 32306.65

60 tablettát	Ft 16144.35	Ft 448.65	Ft 26919.21

30 tablettát		Ft 717.73	Ft 21531.78

24mg

Csomagolás	Megtakarítás	Per tabletta	Ár
120 tablettát	Ft 35844.40	Ft 1646.01	Ft 197521.31
Ingyenes Légiposta
90 tablettát	Ft 18806.64	Ft 1735.75	Ft 156217.64
Ingyenes Légiposta
60 tablettát	Ft 8952.12	Ft 1795.51	Ft 107730.73
Ingyenes Légiposta
36 tablettát	Ft 1786.83	Ft 1895.08	Ft 68222.88
Ingyenes Légiposta
24 tablettát		Ft 1944.71	Ft 46673.14

30mg

Csomagolás	Megtakarítás	Per tabletta	Ár
90 tablettát	Ft 35866.85	Ft 1995.15	Ft 179563.19
Ingyenes Légiposta
60 tablettát	Ft 14339.55	Ft 2154.67	Ft 129280.47
Ingyenes Légiposta
36 tablettát	Ft 3582.64	Ft 2294.15	Ft 82589.37
Ingyenes Légiposta
24 tablettát		Ft 2393.67	Ft 57448.01
Ingyenes Légiposta

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

Hypersensitivity to deflazacort;
Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
Gastrointestinal Perforation: GI disorders;
Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
Effects on Bones: decreases in bone mineral density;
Serious Skin Rashes;
Ophthalmic Effects: May include cataracts, infections, and glaucoma;
Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.